NPA Petitions US FDA To Act On CBD Regulation
Trade Group Suggests Agency Follow UK Food Standards Authority's Example
Executive Summary
NPA head Daniel Fabricant's disappointment about FDA inaction grow as UK makes progress in regulating CBD products. Either deem CBD lawful, or start testing ingredients' safety or conduct rulemaking, NPA urges.
You may also be interested in...
US Supplement Industry Left Waiting For Changes In FDA ‘Unified’ Food Programs Reorganization
“Something needed to be done” to improve FDA’s regulation of human foods supply, says Commissioner Califf says. “Dietary supplements is a whole different kettle of fish that we can discuss at a later time.”
US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry
Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.
Heightening Focus On Hemp, Cannabis, US FDA Hires Norman Birenbaum As Public Health Advisor
Hemp industry and private attorneys glad Birenbaum, who was the chief cannabis policy advisor to governors of New York and Rhode Island, given prominent role at FDA that could spur regulatory action.